| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,624 |
4,460 |
$238K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
564 |
535 |
$212K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
10,886 |
10,534 |
$74K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,171 |
1,152 |
$37K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,170 |
1,152 |
$37K |
| 87486 |
|
564 |
535 |
$18K |
| 87581 |
|
564 |
535 |
$18K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
565 |
536 |
$17K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,438 |
1,432 |
$14K |
| 85027 |
|
932 |
924 |
$6K |
| 87081 |
|
731 |
722 |
$5K |
| 86592 |
|
933 |
929 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
520 |
505 |
$4K |
| 81003 |
|
1,259 |
1,212 |
$3K |
| 82043 |
|
341 |
340 |
$2K |
| 85014 |
|
807 |
785 |
$2K |
| 99000 |
|
553 |
500 |
$2K |
| 82570 |
|
341 |
340 |
$2K |
| 87088 |
|
93 |
91 |
$557.27 |
| 87070 |
|
24 |
24 |
$201.36 |
| 87186 |
|
25 |
25 |
$193.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13 |
13 |
$134.29 |
| 85651 |
|
31 |
30 |
$81.19 |
| 87205 |
|
12 |
12 |
$57.00 |
| 36415 |
Collection of venous blood by venipuncture |
42 |
42 |
$1.08 |